23.10.2020 • NewsPQMergers & Acquisitions (M&A)

PQ Sells Performance Materials to Private Equity

US specialty chemicals company PQ Group has agreed to sell its Performance Materials business to middle-market private equity firm The Jordan Company (TJC) for $650 million. The sale is expected to close by the end of 2020, subject to regulatory approvals and customary conditions.

“The planned sale of Performance Materials at an attractive valuation marks a significant milestone on our ‘Simpler and Stronger’ strategic path, as we target a portfolio reflecting both higher top-line growth and higher margins,” said Belgacem Chariag, PQ’s chairman, president and CEO.

Chariag added that the group’s end goal for its ‘Simpler and Stronger’ plan is to focus on its high-growth, high-margin Catalysts and Refining Services businesses.

Consequently, it is launching a review of strategic alternatives for its Performance Chemicals arm, which Chariag described as “a healthy business with customers and attributes that are distinct from our Catalysts and Refining Services segments.”

PQ expects to use proceeds from the sale of the Performance Materials business along with a portion of existing cash to reduce debt by about $460 million, while also allocating up to $250 million to a planned special dividend to shareholders, which is subject to board approval.

For TJC, the deal is its seventh transaction in the chemicals sector. The New York-based investor also owns specialty polymers and additives company Polymer Solutions Group and specialty chemicals company Vantage.

Author: Elaine Burridge, Freelance Journalist

PQ Group has agreed to sell its Performance Materials business to private...
PQ Group has agreed to sell its Performance Materials business to private equity firm The Jordan Company for $650 million. The sale is expected to close by end 2020. The US group has also launched a strategic review of alternatives for its Performance Chemicals arm. (c) Pexcel

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.